Frost & Sullivan Awards PMD Solutions with Visionary Innovation Leadership Award

Posted by PMD Solutions on Oct 5, 2018 3:53:00 PM

Frost & Sullivan awards PMD Solutions with the 2018 Visionary Innovation Leadership award for the non-invasive respiratory market at the Best Practices banquet in London. Best practice companies lead the way and set the example for others. The Best Practices Awards have identified exemplary achievements within a multitude of industries and functional disciplines for the last 18 years. Frost & Sullivan conducts best practices research to properly identify unrivalled innovation and leadership among companies, products, processes and executives.

This award recognises how this leadership position enables a market participant to deliver highly competitive products and solutions that transform the way individuals and businesses perform daily activities. At the heart of visionary innovation is a deep understanding of the implications and global ramifications of industry Mega Trends.

“With an aggressive strategy for reaching a market leadership position by 2020, and investing over 8 years in designing its industry-leading clinical research programme, PMD is committed to continuing this evidence-based approach to expand its application and geographical reach. In addition, PMD’s growing clinical support and acceptance makes them an exciting company to watch in the European non-invasive respiratory market” says Dorman Followwill, Senior Partner, Transformational Health at Frost & Sullivan.

RespiraSense™, the world’s only continuous and motion-tolerant respiratory rate monitor, is a revolution in early detection of patient deterioration,” says Myles Murray, PMD Solutions CEO. “PMD is honoured to receive this prestigious recognition. This award comes at a time where 8 years of clinical evidence and market acceptance by NHS England and other global leaders in patient monitoring positions PMD for rapid growth. Thereby, contributing to fulfilling PMD’s vision of improving patient outcomes by making every breath count.”

“PMD Solutions’ RespiraSense™ is properly aligned with the future of Frost & Sullivan-identified Mega Trends by reducing the need for healthcare resources, enabling RR data to be transmitted to providers, and sending alerts through wireless sensor platforms.” Brahadeesh C, Industry Analyst, Transformational Health at Frost & Sullivan.

Topics: Press Release, Respiratory Monitoring

Recent posts